Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Dermatologie (Heidelb) ; 74(7): 554, 2023 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-37351612
2.
Dermatologie (Heidelb) ; 74(5): 323-329, 2023 May.
Artículo en Alemán | MEDLINE | ID: mdl-37140636

RESUMEN

Mastocytosis in children is a rare disease characterized by an abnormal accumulation of tissue mast cells. Mastocytosis in children presents with typical skin alterations that are classified as maculopapular cutaneous mastocytosis, diffuse cutaneous mastocytosis, or mastocytoma. Some patients also develop mast cell mediator symptoms, such as pruritus, flush, and anaphylaxis. In many children, the disease is characterized by a benign and usually self-limiting course; systemic mastocytosis with extracutaneous involvement and a chronic or progressive course is found only rarely. Therapeutically, H1 antihistamines are primarily used on an as-needed basis or as continuous treatment, depending on the severity. Children, parents and caregivers should be thoroughly educated about the clinical picture and possible trigger factors of mast cell mediator release. For children with extensive skin alterations and severe symptoms, the prescription of an epinephrine auto-injector is recommended for emergency treatment.


Asunto(s)
Mastocitosis Cutánea , Mastocitosis Sistémica , Mastocitosis , Urticaria Pigmentosa , Humanos , Niño , Mastocitosis/diagnóstico , Mastocitos , Urticaria Pigmentosa/diagnóstico , Mastocitosis Sistémica/diagnóstico , Mastocitosis Cutánea/diagnóstico
3.
Nutrients ; 10(11)2018 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-30400138

RESUMEN

The present human intervention trial investigated the health-promoting potential of B. carinata, with a focus on effects of thermal processing on bioactivity. Twenty-two healthy subjects consumed a B. carinata preparation from raw (allyl isothiocyanate-containing) or cooked (no allyl isothiocyanate) leaves for five days in a randomized crossover design. Peripheral blood mononuclear cells were exposed to aflatoxin B1 (AFB1), with or without metabolic activation using human S9 mix, and subsequently analyzed for DNA damage using the comet assay. Plasma was analyzed for total antioxidant capacity and prostaglandin E2 (PGE2) levels. Cooked B. carinata significantly reduced DNA damage induced by AFB1 as compared to baseline levels (+S9 mix: 35%, -S9 mix: 33%, p ≤ 0.01, respectively). Raw B. carinata only reduced DNA damage by S9-activated AFB1 by 21% (p = 0.08). PGE2 plasma levels were significantly reduced in subjects after consuming raw B. carinata. No changes in plasma antioxidant capacity were detectable. A balanced diet, including raw and cooked Brassica vegetables, might be suited to fully exploit the health-promoting potential. These results also advocate the promotion of B. carinata cultivation in Eastern Africa as a measure to combat effects of unavoidable aflatoxin exposure.


Asunto(s)
Brassica/química , Culinaria , Verduras , Adulto , Antioxidantes/metabolismo , Estudios Cruzados , Dieta , Femenino , Análisis de los Alimentos , Humanos , Isotiocianatos/sangre , Isotiocianatos/metabolismo , Isotiocianatos/orina , Leucocitos Mononucleares , Masculino , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA